Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Cited by (1,005)

Items 901–1,000 of 1,005

1. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
   Sally R. Wilkes, Helen Nankervis, Elsa Tavernier, A. Maruani, Hywel C Williams · 2016 · Journal of Investigative Dermatology
2. Guidelines 2.0: Do No Net Harm—The Future of Practice Guideline Development in Asthma and Other Diseases
   Holger Jens Schünemann · 2011 · Current Allergy and Asthma Reports
3. On Evidence, Medical and Legal
   Donald W. Miller, Clifford G Miller · 2005 · PhilPapers (PhilPapers Foundation)
4. The effect of a conflict of interest disclosure form using closed questions on the number of positive conflicts of interest declared–a controlled study
   Baethge, Christopher · 2013 · PeerJ
5. The New Medical Oikumene
   Healy, David · 2006 · Global Pharmaceuticals
6. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
   Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2022 · Вопросы современной педиатрии
7. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
   Seung‐Kwon Myung, Yunseo Park · 2025 · The American Journal of Medicine
8. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
   Kimberly A. Turner, Andrea Carboni-Jiménez, Carla Benea, Katharine Elder, Brooke Levis, Jill T Boruff, Michelle Roseman, Lisa Anne Bero, Joel Lexchin, Erick H. Turner et al. · 2020 · BMJ Open
9. Methodological and Cognitive Biases in Science: Issues for Current Research and Ways to Counteract Them
   Manuela Fernández Pinto · 2023 · Perspectives on Science
10. Risks and benefits of oral modified‐release compared with oral immediate‐release opioid use after surgery: a systematic review and meta‐analysis
    Shania Liu, Ali Athar, D. Quach, Asad E. Patanwala, Justine Naylor, Jennifer Stevens, Nicholas Levy, Roger Knaggs, Dileep N. Lobo, Jonathan H-D Penm · 2023 · Anaesthesia
11. A systematic review and evaluation of post-stroke depression clinical practice guidelines
    James Graham Cross, Brandon R. May, Peter Q.M., Elizabeth H. Anderson, Connor Welsh, Shaeker Chandran, Kevin T. Chorath, Shelby Herr, Daniel Gonzalez · 2023 · Journal of Stroke and Cerebrovascular Diseases
12. Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity
    Piotr Rzymski, Willis Gwenzi · 2024 · Journal of Medical Virology
13. Compellingness: assessing the practical relevance of clinical research results
    Mark R. Tonelli · 2012 · Journal of Evaluation in Clinical Practice
14. Recommendations for a uniform assessment of publication bias related to funding source
    Marlies van Lent, John Overbeke, Henk Jan Out · 2013 · BMC Medical Research Methodology
15. Cholesterol Screening and Management in Children and Young Adults Should Start Early—NO!
    Alan R. Schroeder, Rita F. Redberg · 2012 · Clinical Cardiology
16. The Cochrane Fertility Regulation Group: synthesizing the best evidence about family planning
    Frans M. Helmerhorst, Toni Belfield, Regina Kulier, Nandita Maitra, Paul O'Brien, David A. Grimes · 2006 · Contraception
17. Are claims of advertisements in medical journals supported by RCTs?
    L. Heimans, Astrid van Hylckama Vlieg, Friedo Wilhelm Dekker · 2010 · PubMed
18. Reporting bias in trials of volume resuscitation with hydroxyethyl starch
    Christian Josef Wiedermann · 2014 · Wiener klinische Wochenschrift
19. In response: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
    Kenneth F. Schulz, Douglas G. Altman, David Moher · 2011 · Annals of Internal Medicine
20. Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey
    Athina Tatsioni, Fotini B. Karassa, Steven N. Goodman, Deborah A. Zarin, Daniele Fanelli, John P. A. Ioannidis · 2019 · Annals of Internal Medicine
21. Informing children and parents about research
    Angus Dawson · 2005 · Archives of Disease in Childhood
22. Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners
    Donna H. Odierna, Jenny White, Susan R. Forsyth, Lisa Anne Bero · 2012 · Health Expectations
23. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression
    Robert Froud, Tom Bjørkli, Philip Bright, Dévan Rajendran, Rachelle Buchbinder, Martin R Underwood, David William Evans, Sandra M Eldridge · 2015 · BMC Musculoskeletal Disorders
24. CRASH (Corticosteroid Randomization after Significant Head Injury Trial): landmark and storm warning.
    M. Bracken · 2005 · Neurosurgery
25. Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft
    Gisela Schott, Rainer Lasek, Wolf-Dieter Ludwig · 2008 · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen
26. Epileptic seizures can follow high doses of oral vardenafil
    Pasquale Striano, Federico Zara, Carlo Minetti, Salvatore Striano · 2006 · BMJ
27. Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets
    L. Ferris, C. Naylor · 2004 · Canadian Medical Association Journal
28. Commentary on Cochrane review of neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
    Mark Jones, Tom Jefferson, Peter Doshi, Chris Del Mar, Carl J. Heneghan, Igho Onakpoya · 2014 · Clinical Microbiology and Infection
29. Sertraline versus other antidepressive agents for depression
    Andrea Cipriani, Teresa La Ferla, Toshi A. Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel C. Churchill, Hugh McGuire, Corrado Barbui · 2010 · Cochrane Database of Systematic Reviews
30. Standardised Data on Initiatives - STARDIT: Alpha Version
    Jack Nunn, Thomas M. A. Shafee, Steven Chang, Richard Stephens, Jim Elliott, Sandy R. Oliver, Denny John, Maureen Smith, Neil Orr · 2019
31. Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey
    Bruno Kovic, Michael J. Zoratti, Steven N. Michalopoulos, Camila Silvestre, Kristian Thorlund, Lehana Thabane · 2017 · Journal of Clinical Epidemiology
32. Sponsorship of oncology clinical trials in the United States according to age of eligibility
    Dylan V. Neel, David Stephen Shulman, Clement Ma, Florence T. Bourgeois, Steven G. DuBois · 2020 · Cancer Medicine
33. Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals
    Richelle J. Cooper, Malkeet Gupta, Michael S. Wilkes, Jerome R. Hoffman · 2006 · Journal of General Internal Medicine
34. Burden of proof: combating inaccurate citation in biomedical literature
    Nicholas Peoples, Truls Østbye, Li-Jing L. Yan · 2023 · British medical journal
35. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis
    Stefano Palomba, Donatella Caserta, Paolo Emanuele Levi-Setti, Andrea Busnelli · 2024 · Journal of Ovarian Research
36. Education in Health Research Methodology: Use of a Wiki for Knowledge Translation
    Michele P Hamm, Terry Paul Klassen, Shannon D. Scott, David Moher, Lisa Hartling · 2013 · PLoS ONE
37. Using Evidence in Pain Practice: Part II: Interpreting and Applying Systematic Reviews and Clinical Practice Guidelines
    Roger Chou · 2008 · Pain Medicine
38. Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument
    Xiaowei Zhang, Kun Zhao, Zhenggang Bai, Jing Yu, Feng Bai · 2016 · American Journal of Cardiovascular Drugs
39. The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies
    Rosa Gini, Xavier Fournie, Helen M. Dolk, Xavier Kurz, Patrice Verpillat, François Simondon, Valerie Strassmann, Kathi Apostolidis, Thomas Goedecke · 2019 · Pharmacoepidemiology and Drug Safety
40. Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
    Mark A. Yarborough · 2020 · Journal of Medical Ethics
41. A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials
    Veranyuy Ngah, Akhona Victress Mazingisa, Moleen Zunza, Charles Shey Wiysonge · 2020 · Vaccines
42. Critical appraisal of systematic reviews of intervention in dentistry published between 2019-2020 using the AMSTAR 2 tool
    Patrícia Pauletto, Helena Polmann, Jéssica Conti Réus, Júlia Meller Dias de Oliveira, Débora Chaves, Karyn Munyk Lehmkuhl, Carla Massignan, Cristine Miron Stefani, Carolina Castro Martins, Carlos Flores‐Mir et al. · 2022 · Evidence-Based Dentistry
43. Will Lower Drug Prices Jeopardize Drug Research? A Policy Fact Sheet
    Donald W. Light, Joel Lexchin · 2004 · The American Journal of Bioethics
44. Research from tobacco industry affiliated authors: need for particular vigilance
    Simon F Chapman · 2005 · Tobacco Control
45. Disclosing conflicts of interest in German publications concerning health services research
    Nils Schneider, Heidrun Lingner, Friedrich Wilhelm Schwartz · 2007 · BMC Health Services Research
46. Acupuncture for Major Depressive Disorder
    Albert Yeung, David Mischoulon · 2007 · The Journal of Clinical Psychiatry
47. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners’ confidence in conclusions, a three-arm randomized controlled trial
    Céline Buffel du Vaure, Isabelle Boutron, Élodie Perrodeau, Philippe Ravaud · 2014 · BMC Medicine
48. Do health care institutions value research? A mixed methods study of barriers and facilitators to methodological rigor in pediatric randomized trials
    Michele P Hamm, Shannon D. Scott, Terry Paul Klassen, David Moher, Lisa Hartling · 2012 · BMC Medical Research Methodology
49. The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map
    Anneliese Synnot, Peter Bragge, Carole Lunny, David Krishna Menon, Ornella Clavisi, Loyal Pattuwage, Victor Volovici, Stefania Mondello, Maryse C. Cnossen, Emma Donoghue et al. · 2018 · PLoS ONE
50. Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years
    Uma Borate, Brianna A. Norris, Abby B. Statler, Rongwei F. Fu, Taylor Bucy, Mikkael Aaron Sekeres · 2019 · Blood Advances
51. Improving study design for antidepressant effectiveness assessment
    Florian Naudet, Bruno Millet, Jean Michel Reymann, Bruno Falissard · 2013 · International Journal of Methods in Psychiatric Research
52. Commentary with a Historical Perspective by a Child Psychiatrist: When “ADHD” Was the “Brain-Damaged Child”
    Leon Eisenberg · 2007 · Journal of Child and Adolescent Psychopharmacology
53. Embedding values: how science and society jointly valence a concept—the case of ADHD
    Susan C. C. Hawthorne · 2010 · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences
54. Rethinking Antipsychotic Formulary Policy
    Robert Alan Rosenheck, DOUGLAS L. LESLIE, Susan H. Busch, Ethan Samuel Rofman, Michael J. Sernyak · 2007 · Schizophrenia Bulletin
55. The surviving sepsis guidelines: “Lost in translation”*
    Dante L. Landucci · 2004 · Critical Care Medicine
56. Conflict of Interest in Peer-Reviewed Medical Journals: The World Association of Medical Editors Position on a Challenging Problem
    Lorraine E. Ferris, Robert Huntington Fletcher · 2010 · Journal of Young Pharmacists
57. A stand against drug company advertising
    George Alexander Jelinek, Anthony FT Brown · 2011 · Emergency Medicine Australasia
58. What’s in a p? Reassessing Best Practices for Conducting and Reporting Hypothesis-Testing Research
    Klaus E. Meyer, Arjen C. van Witteloostuijn, Sjoerd Beugelsdijk · 2019 · JIBS special collections
59. Milnacipran versus other anti-depressive agents for depression
    Atsuo Nakagawa, Norio Watanabe, Ichiro M Omori, Andrea Cipriani, Corrado Barbui, Hugh McGuire, Rachel C. Churchill, Toshi A. Furukawa, Meta-Analysis of New Generation Ant · 2007 · Cochrane Database of Systematic Reviews
60. Industry-Funded Research and Bias in Food Science
    Anita Rao · 2020 · Quantitative Marketing and Economics
61. Effectiveness of atypical antipsychotics for unipolar and bipolar depression in adolescents and young adults: A systematic review and meta-analysis
    Louise Garcia-Rodriguez, D Burton, Christine A. Leonards, Christopher G. Davey · 2023 · Journal of Affective Disorders
62. The Problem of Biased Data and Potential Solutions for Health and Environmental Assessments
    Glenn W. Suter, Susan M. Cormier · 2014 · Human and Ecological Risk Assessment An International Journal
63. Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry
    Veerasathpurush Allareddy, Sankeerth Rampa, Mohamed I. Masoud, Min Kyeong Lee, Romesh P. Nalliah, Veerajalandhar Allareddy · 2014 · American Journal of Orthodontics and Dentofacial Orthopedics
64. The unobtainable placebo: control of independent clinical research by industry?
    Mikkel Christensen, Filip Krag Knop · 2012 · The Lancet
65. How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol
    Susan L. Armijo-Olivo, Jorge Fuentes, Todd Rogers, Lisa Hartling, Humam Saltaji, Greta G. Cummings · 2013 · Systematic Reviews
66. Commercialization and Stem Cell Research: A Review of Emerging Issues
    Sarah Burningham, Adam Ollenberger, Timothy Caulfield · 2013 · Stem Cells and Development
67. Acute otitis media in children with tympanostomy tubes.
    Jason Schmelzle, Richard Birtwhistle, Andre K.W. Tan · 2008 · PubMed Central
68. Coping with the Conflict-of-Interest Pandemic by Listening to and Doubting Everyone, Including Yourself
    Lynn T. Kozlowski · 2015 · Science and Engineering Ethics
69. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Translation to Russian
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2021 · Digital Diagnostics
70. Drug Class Review: Atypical Antipsychotic Drugs
    Marian S. McDonagh, Kim Peterson, Susan Carson, Rochelle Fu, Sujata Thakurta · 2010
71. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
    F. Alfonso, A. Timmis, F. Pinto, G. Ambrosio, H. Ector, P. Kulakowski, P. Vardas, L. Antoniades, Mansoor Ahmad, E. Apetrei et al. · 2011 · Heart
72. Funding sources and financial disclosures, and their relationship to study outcomes and level of evidence in the Journal of Shoulder and Elbow Surgery
    Zachary C. Foughty, Matthew S. Antalis, Jonathan D. Ringenberg, Adam D. Hall · 2017 · Journal of Shoulder and Elbow Surgery
73. Introduction of Novel Medical Devices in Surgery: Ethical Challenges of Current Oversight and Regulation
    Ivo S. Muskens, Saksham Gupta, Alexander F. C. Hulsbergen, Wouter A. Moojen, Marike L. D. Broekman · 2017 · Journal of the American College of Surgeons
74. Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis
    Alberto Falk Delgado, Anna Falk Delgado · 2017 · Scientific Reports
75. Reporting characteristics of case reports of acupuncture therapy with CARE guidelines
    Guanghui An, Xiaoting Tang, Yaolong Chen, Yi Zhao · 2017 · Chinese Journal of Integrative Medicine
76. Ciência, tecnologia e inovação em saúde e desenvolvimento social e qualidade de vida: teses para debate
    Hillegonda Maria Dutilh Novaes, José da Rocha Carvalheiro · 2007 · Ciência & Saúde Coletiva
77. Disclosure in Regulatory Science
    David Michaels, Wendy E Wagner · 2003 · Science
78. Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
    Tomas Philipson, George Zanjani · 2013 · National Bureau of Economic Research
79. The Sound and the Fury: Financial Conflicts of Interest in Oncology
    Benjamin Djulbegović, Cara Angelotta, Kjersti E. Knox, Charles Lee Bennett · 2007 · Journal of Clinical Oncology
80. Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians
    Anju Murayama, Yuki Senoo, Kayo Shirado Harada, Yasuhiro Kotera, Hiroaki Saito, Toyoaki Sawano, Yosuke Suzuki, Tetsuya E. Tanimoto, Akihiko Ozaki · 2022 · International Journal of Environmental Research and Public Health
81. Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One?
    Emma D'Arcy, Ray N Moynihan · 2009 · PLoS Medicine
82. Results and Outcome Reporting In ClinicalTrials.gov, What Makes it Happen?
    Olga Kirillova · 2012 · PLoS ONE
83. Conflicts of Interest in Recommendations to Use Computerized Neuropsychological Tests to Manage Concussion in Professional Football Codes
    Bradley Partridge, Wayne Hall · 2013 · Neuroethics
84. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review
    Jéssica Yumi Matuoka, James G. Kahn, Sílvia Regina Secoli · 2018 · The European Journal of Health Economics
85. Directing scientists away from potentially biased publications: the role of systematic reviews in health care
    Rossella Salandra, Paola Criscuolo, Ammon J. Salter · 2020 · Research Policy
86. How transparent is behavioral intervention research on pathological gambling and other gambling‐related disorders? A systematic literature review
    Arlène Fink, Iman Parhami, Richard J. Rosenthal, Michael D. Campos, Aaron Siani, TIMOTHY W. FONG · 2012 · Addiction
87. The ethics of the medical-pharmaceutical relationship
    Neelam A. Vashi, Jo-Ann M. Latkowski · 2012 · Clinics in Dermatology
88. Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair
    François Montastruc, Guillaume Moulis, Aurore Palmaro, Virginie Gardette, Geneviève Durrieu, Jean‐Louis Montastruc · 2014 · PLoS ONE
89. Role of Physician Gender in Drug Therapy
    Ioanna Gouni‐Berthold, Heiner K. Berthold · 2012 · Handbook of experimental pharmacology
90. The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis
    Lewis O. J. Killin, Tom C. Russ, John M. Starr, Sharon Abrahams, Sergio Della Sala · 2014 · BMJ Open
91. Qualichem In Vivo: A Tool for Assessing the Quality of In Vivo Studies and Its Application for Bisphenol A
    Laura Maxim, Jeroen P. van der Sluijs · 2014 · PLoS ONE
92. Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey
    Maria Elena Flacco, Lamberto Manzoli, Stefania Boccia, Anna Puggina, Annalisa Rosso, Carolina Marzuillo, Giacomo Scaioli, Maria Rosaria Gualano, Walter Ricciardi, Paolo Villari et al. · 2016 · Mayo Clinic Proceedings
93. Automatic identification of high impact articles in PubMed to support clinical decision making
    Jiantao Bian, Mohammad Amin Morid, Siddhartha Jonnalagadda, Gang Luo, Guilherme Del Fiol · 2017 · Journal of Biomedical Informatics
94. Interventions for female pattern hair loss
    2012 · Prescriber
95. The Commercialization of Research and the Quest for the Objectivity of Science
    Saana Jukola · 2014 · Foundations of Science
96. The Relationship between the Outcome of Studies of Autologous Chondrocyte Implantation and the Presence of Commercial Funding
    James H. Lubowitz, David Appleby, Joseph M. Centeno, Shane K. Woolf, John B. Reid · 2007 · The American Journal of Sports Medicine
97. Releasing Psychiatry from the Constraints of Categorical Diagnosis
    Graham W Mellsop, David Benjamin Menkes, Selim M. El-Badri · 2007 · Australasian Psychiatry
98. The need for publishing the silent evidence from negative trials
    Francesc Colom, Eduard Vieta · 2011 · Acta Psychiatrica Scandinavica
99. The Future of Physical & Rehabilitation Medicine as a Medical Specialty in the Era of Evidence-Based Medicine
    GEROLD R. EBENBICHLER, Katharina Kerschan‐Schindl, Thomas Brockow, Karl Ludwig Resch · 2008 · American Journal of Physical Medicine & Rehabilitation
100. Hipertensión pulmonar: eficacia clínica del sildenafilo en clases funcionales II-III
     Isabel Otero González, Marina Blanco‐Aparicio, Ana Souto-Alonso, Inés Raposo Sonnenfeld, Héctor Verea Hernando · 2007 · Archivos de Bronconeumología